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This group further mandates review of all research by outside health care providers and the release of both positive and negative results to the public.
Guided in part by the approach of the Parkinson Study Group, a large multisite study-the National Institute on Aging (NIA) Cooperative Study-has developed and internally disseminated conflict-of-interest guidelines. These include a $10000 annual cap on consulting fees for investigators and stringent limitations on ownership of equity in companies involved in the studies. Those leading the studies are subject to stricter guidelines. However, the blanket exclusion of experts with some industry ties from the design of trials might make drug development less efficient. Therefore, the Cooperative Study's guidelines reflect a need to balance access to scientific expertise with the goal of mitigating conflicts of interest. The group is currently studying the impact of its guidelines on the conduct of clinical trials.
Novel targets of AD pathogenesis, however, would present a new set of challenges even if all appearances of conflict were to be addressed. A recent trial of a vaccine-based treatment for AD 8 was viewed by many as a critical test of the amyloid hypothesis, a popular model of AD pathogenesis. Vaccination of transgenic mice against components of human amyloid, a protein at the core of senile plaques in AD, led to clearance of this protein from the brain. 9 However, in phase II human trials with this same vaccine, some subjects developed autoimmune encephalitis, an adverse effect that prompted termination of the trial. 10 As others have suggested, the public health can best be served in this case by a full disclosure of the disease course and clinical response of all trial participants, 11 rather than analyses of single cases 8 or subsets of subjects. 12 Equipped with as complete a set of positive and negative findings as possible, clinical investigators would be better able to anticipate potential problems with mechanistically novel agents in future trials.
